rizatriptan + caffeine

Rizatriptan + caffeine is a hypothetical or investigational combination of two active ingredients used for the acute treatment of migraine headaches. Rizatriptan is a selective serotonin (5-HT1B/1D) receptor agonist, commonly known as a "triptan," which works by constricting intracranial blood vessels, inhibiting neuropeptide release, and reducing transmission in the trigeminal pain pathway to relieve migraine symptoms[4][6]. Caffeine is a central nervous system stimulant that can enhance the effectiveness of certain analgesics and has vasoconstrictive properties. While combinations like aspirin/acetaminophen/caffeine are marketed for migraines (e.g., Excedrin Migraine), there are no approved or widely available pharmaceutical products combining rizatriptan with caffeine[1]. The rationale for such a combination would be to potentially improve efficacy in acute migraine relief by leveraging both mechanisms.